Skip to main content
SpringerLink
Log in

Acetylcholinesterase Inhibitors May Improve Efficacy and Reduce Adverse Effects of Tricyclic Antidepressants for Depression

  • Correspondence
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Passmore MJ, Gardner DM, Polak Y, et al. Alternatives to atypical antipsychotics for the management of dementia-related agitation. Drugs Aging 2008; 25(5): 381–98

    Article  PubMed  CAS  Google Scholar 

  2. Figiel G, Sadowski C. A systematic review of the effectiveness of rivastigmine for the treatment of behavioural disturbances in dementia and other neurological disorders. Curr Med Res Opin 2008; 24: 157–66

    Article  PubMed  CAS  Google Scholar 

  3. Onor ML, Trevisiol M, Aguglia E. Rivastigmine in the treatment of Alzheimer’s disease: an update. Clin Interv Aging 2007; 2: 17–32

    Article  PubMed  CAS  Google Scholar 

  4. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: an overview. Ann N Y Acad Sci 2001; 931: 1–16

    Article  PubMed  CAS  Google Scholar 

  5. Cancelli I, Marcon G, Balestieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol 2004; 19(8): 577–84

    Article  PubMed  CAS  Google Scholar 

  6. Hay F, Linkowski P. Antidepressants: TCA versus SSRI versus other new agents [in French]. Rev Med Brux 2004; 25(4): A315–20

    PubMed  CAS  Google Scholar 

  7. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58: 19–36

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this correspondence. The author has no conflicts of interest that are directly relevant to the content of this correspondence.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy

    Helmut Niederhofer

Authors
  1. Helmut Niederhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niederhofer, H. Acetylcholinesterase Inhibitors May Improve Efficacy and Reduce Adverse Effects of Tricyclic Antidepressants for Depression. Drugs Aging 25, 715 (2008). https://doi.org/10.2165/00002512-200825080-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825080-00008

Keywords

Search

Navigation